Hardy Reed’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$241K Sell
2,785
-161
-5% -$15.4K 0.02% 219
2025
Q4
$283K Buy
2,946
+129
+5% +$12.5K 0.02% 197
2025
Q3
$268K Buy
2,817
+231
+9% +$21.2K 0.02% 204
2025
Q2
$225K Sell
2,586
-14
-0.5% -$1.19K 0.02% 229
2025
Q1
$234K Sell
2,600
-143
-5% -$12.8K 0.02% 213
2024
Q4
$219K Hold
2,743
0.02% 233
2024
Q3
$247K Buy
2,743
+116
+4% +$9.76K 0.02% 214
2024
Q2
$207K Buy
+2,627
New +$215K 0.02% 224

Other funds holding MDT

Hardy Reed's MDT Position: Q1 2026 in Review

Hardy Reed reduced its Medtronic (MDT) stake by 5.5% in Q1 2026, selling an estimated $15.4K and leaving 2,785 shares worth $241K. The position accounts for 0.02% of the portfolio, ranked #219.

Hardy Reed first reported a position in MDT in Q2 2024 and has held it in 8 quarters since. The position peaked at $283K in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hardy Reed held 2,785 shares of Medtronic worth $241K as of Q1 2026.
  • Hardy Reed sold 161 Medtronic shares in Q1 2026, an estimated $15.4K.
  • Medtronic made up 0.02% of Hardy Reed's portfolio in Q1 2026, its #219 holding.
  • Hardy Reed first reported a position in Medtronic in Q2 2024 and has held it in 8 quarters since.
  • Hardy Reed's Medtronic position peaked at $283K in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.